{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:19:17Z","timestamp":1761016757488},"publisher-location":"Chichester, UK","reference-count":18,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd005612.pub2","type":"reference-entry","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T01:11:33Z","timestamp":1202260293000},"source":"Crossref","is-referenced-by-count":7,"title":["Pregabalin add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"Jennifer","family":"Pulman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Hemming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD005612.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"issue":"91","key":"10.1002\/14651858.CD005612.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures","volume":"1","author":"Baulac","year":"2010","journal-title":"Epilepsy Research"},{"issue":"3","key":"10.1002\/14651858.CD005612.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD005612.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"issue":"10","key":"10.1002\/14651858.CD005612.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005612.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1167.2008.01954.x","article-title":"Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double-blind, randomized, placebo-controlled, multicenter trial","volume":"50","author":"Lee","year":"2009","journal-title":"Epilepsia"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD005612.pub2-BIB7|cit7","first-page":"172","article-title":"Comparative dosage adjustment of levetiracetam and pregabalin as adjunctive therapy for refractory partial epilepsy with polytherapy. A prospective observational randomized study","volume":"47","author":"Russi","year":"2006","journal-title":"Epilepsia"},{"issue":"Suppl 7","key":"10.1002\/14651858.CD005612.pub2-BIB8|cit8","first-page":"69","article-title":"Open label, randomised, cross-over trial in epilepsy patients with cryptogenic focal, refractory epilepsy, comparing levetiracetam and pregabalin as add-on therapy","volume":"484","author":"Tata","year":"2007","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005612.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1528-1167.2005.19204.x","article-title":"Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"issue":"8968","key":"10.1002\/14651858.CD005612.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD005612.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1528-1157.1989.tb05317.x","article-title":"Inhibition of neuronal (Ca2+) influx by gabapentin and pregabalin in human neocortex","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1002\/14651858.CD005612.pub2-BIB12|cit12","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Epilepsy: Frequency, Causes and Consequences","author":"Hauser","year":"1990"},{"volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]. The Cochrane Collaboration","year":"2011","author":"Higgins","key":"10.1002\/14651858.CD005612.pub2-BIB13|cit13"},{"issue":"4","key":"10.1002\/14651858.CD005612.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1528-1157.1989.tb05317.x","article-title":"Guidelines for clinical evaluation of antiepileptic drugs","volume":"30","year":"1989","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD005612.pub2-BIB15|cit15","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD005612.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/1097-0258(20001230)19:24<3417::AID-SIM614>3.0.CO;2-L","article-title":"A multilevel model framework for meta-analysis of clinical trials with binary outcomes","volume":"19","author":"Turner","year":"2000","journal-title":"Statistics in Medicine"},{"issue":"Spec No.1","key":"10.1002\/14651858.CD005612.pub2-BIB17|cit17","first-page":"5S376","article-title":"[Quality-of-life scales for patients with drug-resistant partial epilepsy]","volume":"160","author":"Villeneuve","year":"2004","journal-title":"Reviews of Neurology (Paris)"},{"issue":"1","key":"10.1002\/14651858.CD005612.pub2-BIB18|cit18","article-title":"Pregabalin add-on for drug-resistant partial epilepsy","author":"Lozsadi","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD005612.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:51:35Z","timestamp":1628545895000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD005612.pub2"}},"subtitle":[],"editor":[{"given":"Jennifer","family":"Pulman","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005612.pub2","relation":{},"subject":[],"published":{"date-parts":[[2008,1,23]]}}}